Top Companies in Veterinary Regenerative Medicine Market by Size, Share, Historical and Future Data & CAGR | Report by Vantage Market Research
Veterinary Regenerative Medicine Market is expected to reach USD 1,283.8 Million by the year 2030 at a recorded CAGR (Compound Annual Market Growth) of 12.90% over the forecast period.
Coralia.Joe
Vantage Market Research has recently published a new report on the “Veterinary Regenerative Medicine Market” Global Industry Assessment & Forecast to identify key trends and challenges. This report offers insights into the competitive landscape, prospects, and key investment considerations for businesses operating in the veterinary regenerative medicine market. Some of the key statistics in this report highlight that the global veterinary regenerative medicine market was valued at USD 549.1 Million in 2022 and is expected to reach USD 1,283.8 Million by the year 2030 at a recorded CAGR (Compound Annual Market Growth) of 12.90% over the forecast period. The global veterinary regenerative medicine market will continue to expand due to rising demand from different end-user sectors, including veterinary clinics, veterinary hospitals, research institutions, and academic centers.
Request Sample Report of Veterinary Regenerative Medicine Market @ https://www.vantagemarketresearch.com/veterinary-regenerative-medicine-market-2153/request-sample
The veterinary regenerative medicine market is a rapidly growing industry, with increasing demand for innovative and effective therapies to improve animal health. The market is being driven by factors such as the rising prevalence of chronic diseases in animals, the growing adoption of stem cell therapy, and advancements in technology. Some of the leading companies in this market include Ardent Animal Health (U.S.), VetStem Biopharma, Inc. (U.S.), Aratana Therapeutics, Inc. (U.S.), Zoetis, Inc. (U.S.), Avita Medical (U.S.), Mesoblast Ltd. (Australia), VetCell Therapeutics (U.S.), RepliCel Life Sciences, Inc. (Canada), Animal Cell Therapies, Inc. (U.S.), and SAGE Veterinary Centers (U.S.).
These companies are focused on developing and commercializing novel regenerative therapies for various animal diseases and injuries. Ardent Animal Health, for instance, specializes in the development and manufacturing of innovative regenerative therapies for dogs and horses, while VetStem Biopharma, Inc. offers stem cell therapy for a wide range of conditions in dogs, cats, and horses. Other companies, such as Aratana Therapeutics, Inc. and Zoetis, Inc., are focused on developing innovative drug therapies for animal health. With the growing demand for eco-friendly and sustainable products in the animal healthcare industry, these companies are well-positioned to capitalize on the growth opportunities in the global veterinary regenerative medicine market.
Let’s Take a Look at the Top Market Players that are Captivating the Veterinary Regenerative Medicine Market
- Ardent Animal Health (U.S.)
Previously known as Medivet Biologics, Ardent Animal Health is a leading company in the veterinary regenerative medicine market, headquartered in Irving, Texas. The company specializes in developing and manufacturing innovative regenerative therapies for dogs and horses. Ardent Animal Health has a presence across North America and Europe, with multiple offices and facilities. The company has over 200 employees and plans to expand its product portfolio and geographic reach in the coming years.
- VetStem Biopharma, Inc. (U.S.)
VetStem Biopharma is a biotechnology company headquartered in Poway, California, focused on providing stem cell therapy for a wide range of conditions in dogs, cats, and horses. The company has a presence across North America and Europe, with multiple offices and facilities. VetStem Biopharma has over 40 employees and plans to expand its product offerings and continue research and development in regenerative medicine.
- Aratana Therapeutics, Inc. (U.S.)
Aratana Therapeutics is a veterinary pharmaceutical company headquartered in Leawood, Kansas, focused on developing innovative drug therapies for animal health. The company has a presence across North America and Europe, with multiple offices and facilities. Aratana Therapeutics has over 100 employees and is focused on expanding its product portfolio and exploring new opportunities in the veterinary regenerative medicine market.
- Zoetis, Inc. (U.S.)
Zoetis is a global animal health company headquartered in Parsippany, New Jersey, with a presence across North America, Europe, Asia, and Latin America. The company has multiple offices and facilities and employs over 10,000 people worldwide. Zoetis is focused on developing and commercializing innovative animal health products and solutions, including those in the regenerative medicine space.
- Avita Medical (U.S.)
Avita Medical is a regenerative medicine company that specializes in developing and commercializing advanced therapies for skin regeneration. The company's headquarters are located in Valencia, California, and it has a global presence with operations in Europe, Asia, and Australia. Avita Medical has over 300 employees and is dedicated to improving patient outcomes by advancing the field of regenerative medicine.
- Mesoblast Ltd. (Australia)
Mesoblast Ltd. is a global leader in regenerative medicine that specializes in developing and commercializing cell-based therapies for a range of diseases. The company's headquarters are located in Melbourne, Australia, and it has operations in North America, Europe, and Asia. Mesoblast has over 300 employees and is dedicated to improving patient outcomes through the development of innovative therapies.
- VetCell Therapeutics (U.S.)
VetCell Therapeutics is a veterinary regenerative medicine company headquartered in Skokie, Illinois, focused on developing and commercializing stem cell therapies for various animal diseases and injuries. The company has a presence across North America, with multiple offices and facilities. VetCell Therapeutics has over ten employees and is focused on expanding its product portfolio and exploring new opportunities in the market.
- RepliCel Life Sciences, Inc. (Canada)
RepliCel Life Sciences Inc. is a regenerative medicine company that specializes in developing and commercializing cell-based therapies for hair regeneration and tendon repair. The company's headquarters are located in Vancouver, Canada, and it has a global presence with operations in Europe and Asia. RepliCel has a team of approximately 15 employees and is dedicated to improving patient outcomes through the use of regenerative medicine.
- Animal Cell Therapies, Inc. (U.S.)
Animal Cell Therapies is a veterinary regenerative medicine company headquartered in San Diego, California, focused on developing and commercializing stem cell therapies for various animal diseases and injuries. The company has a presence across North America, with multiple offices and facilities. Animal Cell Therapies has over ten employees and is focused on expanding its product portfolio and exploring new opportunities in the market.
- SAGE Veterinary Centers (U.S.)
SAGE Veterinary Centers is a US-based network of specialty and emergency veterinary hospitals that offer advanced medical care for pets. They have a dedicated regenerative medicine department that provides stem cell therapy and platelet-rich plasma treatments for various conditions, including orthopedic injuries, immune-mediated diseases, and degenerative conditions. SAGE Veterinary Centers have several locations in California, with plans to expand to other regions in the United States. They employed a team of over 600 people and generated $100 million in revenue in 2020.
Read Our Latest Blog: Top Companies in Pharmaceutical Drug Delivery Market
Do You Have Any Queries or Specific Requirements? You may enquire to our sales team before purchasing.
Contact us
Eric Kunz
6218 Georgia Avenue NW Ste 1 - 564
Washington DC 20011-5125
United States Tel: +1 202 380 9727
Email: [email protected]
Website: Vantage Market Research
